Publications by authors named "Lars C Wallentin"

Claim this Profile
L
Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran.
Jennifer M Kolb, Kathryn Friedman Flack, Prapti Chatterjee-Murphy, Jay Desai, Lars C Wallentin

Dig Dis Sci· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation.
Kathryn F Flack, Jay Desai, Jennifer M Kolb, Prapti Chatterjee, Lars C Wallentin

Clin Gastroenterol Hepatol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third universal definition of myocardial infarction.
Kristian Thygesen, Joseph S Alpert, Allan S Jaffe, Maarten L Simoons, Bernard R Chaitman, Lars C Wallentin

Eur Heart J· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third universal definition of myocardial infarction.
Kristian Thygesen, Joseph S Alpert, Allan S Jaffe, Maarten L Simoons, Bernard R Chaitman, Lars C Wallentin

Circulation· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third universal definition of myocardial infarction.
Kristian Thygesen, Joseph S Alpert, Allan S Jaffe, Maarten L Simoons, Bernard R Chaitman, Lars C Wallentin

J Am Coll Cardiol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
Richard C Becker, John H Alexander, L Kristin Newby, Hongqiu Yang, Yuchen Barrett, Lars C Wallentin

Thromb Haemost· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular disease on a global scale: defining the path forward for research and practice.
Daniel B Mark, Frans J Van de Werf, R John Simes, Harvey D White, Lars C Wallentin

Eur Heart J· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal definition of myocardial infarction.
Kristian Thygesen, Joseph S Alpert, Harvey D White, , Allan S Jaffe, Lars C Wallentin

Circulation· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups.
Adrián V Hernández, Cynthia M Westerhout, Ewout W Steyerberg, John P A Ioannidis, Héctor Bueno, Lars C Wallentin

Heart· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes.
Cynthia M Westerhout, Adrián V Hernández, Ewout W Steyerberg, Héctor Bueno, Harvey White, Lars C Wallentin

Eur Heart J· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the structure, organization, and operation of intensive cardiac care units.
Yonathan Hasin, Nicolas Danchin, Gerasimos S Filippatos, Magda Heras, Uwe Janssens, Lars C Wallentin

Eur Heart J· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
Michel E Bertrand, Maarten L Simoons, Keith A A Fox, Lars C Wallentin, Christian W Hamm

Eur Heart J· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.
Eric Boersma, Robert A Harrington, David J Moliterno, Harvey White, Pierre Théroux, Lars C Wallentin

Lancet· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis